nDatalyze Corp. (CSE:NDAT)
Canada · Delayed Price · Currency is CAD | Market Cap | 619.91K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -232.35K |
| Shares Out | 41.33M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 129 |
| Average Volume | 450 |
| Open | 0.0150 |
| Previous Close | 0.0150 |
| Day's Range | 0.0150 - 0.0150 |
| 52-Week Range | 0.0150 - 0.1400 |
| Beta | 0.06 |
| RSI | 40.45 |
| Earnings Date | Oct 27, 2025 |
About nDatalyze
nDatalyze Corp. provides technologically based solutions related to applying machine learning to a records database to predict probable mental health conditions. It offers Sigmund, a machine-learning-based online mental health application for the mental health system, such as misdiagnosis and mis prescription. The company was formerly known as MedXtractor Corp. and changed its name to nDatalyze Corp. in October 2021. nDatalyze Corp. was incorporated in 2018 and is headquartered in Calgary, Canada. [Read more]
Financial Performance
In 2024, nDatalyze's revenue was 1,714, a decrease of -98.22% compared to the previous year's 96,342. Losses were -554,476, 256.3% more than in 2023.
Financial StatementsNews
nDatalyze Corp. updates the "Epitome" Predictive Sports Performance Analytics Project and the RTO progress.
Calgary, Alberta – October 20, 2025 – TheNewswire – nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE: NDAT) (OTCQB: NDATF) is pleased to announce the completion of the genetic swab and Questionnaire...
nDatalyze Corp. updates the "Epitome" Predictive Sports Performance Analytics Project and the RTO progress
Calgary, Alberta – TheNewswire - September 30, 2025 – nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE: NDAT) (OTCQB: NDATF) is pleased to announce that the sports analytics predictive scoring formu...
nDatalyze Corp. announces initiation of "Epitome", a Predictive Sports Performance Project leveraging AI to address a Multi-Billion Dollar Sports Analytics Market
Calgary, Alberta – TheNewswire - September 4, 2025 – nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE: NDAT) (OTCQB: NDATF) is pleased to announce the initiation of “Epitome”, a next-generation spor...